Akif AYAZ, Emre TEPELİ, İnci GÜÇTÜRK, Özmert M.A. ÖZDEMİR, Hazal TANCER-ELÇİ, Selcan ZEYBEK, Aziz POLAT

Familial mutation in Caffey disease with reduced penetrance: A case report

demir ÖMA, Tancer-Elçi H, Polat A, Güçtürk İ, Tepeli E, Zeybek S, Ayaz A. Familial mutation in Caffey disease with reduced penetrance: A case report. Turk J Pediatr 2016; 58: 650-653.Caffey disease is a rare condition of early infancy, characterized by soft tissue swelling, bone lesions, and hyperirritability. Its typical radiological finding is periosteal new bone formation. It can be sporadic or inherited in an autosomal dominant manner. There is no specific treatment. In symptomatic cases, non-steroidal anti-inflammatory drugs such as ibuprofen, indomethacin, or naproxen can be used. This is a report of an infant who presented with restlessness, irritability, and swelling over his shins, diagnosed as Caffey disease. Although there was no family history, the genetic analysis revealed heterozygous missense mutation (c.3040C>T) in type-I-collagen-alpha-1-chain gene in the patient in addition to his mother, grandmother, aunt, and cousin. After indomethacin therapy, the complaints of the patient were completely resolved and his bone lesions were significantly improved. This case report is a familial form of Caffey disease from Turkey, with proven heterozygous mutation in the patient and the family members

PDF

___

Caffey J, Silverman W. Infantile cortical hyperostosis, preliminary report of a new syndrome. Am J Roentgenol Rad Therapy 1945; 54: 1-16.
Caffey J. Infantile cortical hyperostosis; a review of the clinical and radiographic features. Proc R Soc Med 1957; 50: 347-354.
Kutty N, Thomas D, George L, John TB. Caffey disease or infantile cortical hyperostosis: A case report. Oman Med J 2010; 25: 134-136.
Caksen H, Cesur Y, Odabas D, Aslan H, Rastgeldi L. A case of infantile cortical hyperostosis. J Nihon Med Sch 2001; 68: 442-443.
Cho TJ, Moon HJ, Cho DY, et al. The c.3040C > T mutation in COL1A1 is recurrent in Korean patients with infantile cortical hyperostosis (Caffey disease). J Hum Genet 2008; 53: 947-949.
Gensure RC, Mäkitie O, Barclay C, et al. A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen- related disorders. J Clin Invest 2005; 115: 1250-1257.
Wagner JM, Solomon A. Hyperostosis corticalis infantalis (Caffey’s disease). S Afr Med J 1969; 43: 754-755.
Glorieux FH. Caffey disease: an unlikely collagenopathy. J Clin Invest 2005; 115: 1142-1144.
Mishra P, Panda SS, Tripathy M, Panda M, Das RR. Infantile cortical hyperostosis: two cases with varied presentations. J Clin Diagn Res 2014; 8: PJ01-2.
Challapalli M, Cunningham DG, Varnado SC. Infantile cortical hyperostosis and facial nerve palsy. Int J Pediatr Otorhinolaryngol 1998; 43: 175-178.
Sheppard JJ, Pressman H. Dysphagia in Infantile cortical hyperostosis (Caffey’s disease): A case study. Dev Med Child Neurol 1988; 30: 111-114.
Bernstein RM, Zaleska DJ. Familial aspects of Caffey’s disease. Am J Orthop (Belle Mead NJ) 1995; 24: 777- 781.
Ranganath P, Laine CM, Gupta D, Makitie O, Phadke SR. COL1A1 mutation in an Indian child with Caffey disease. Indian J Pediatr 2011; 78: 877-879.
Lo HP, Lau HY, Li CH, So KT. Infantile cortical hyperostosis (Caffey disease): a possible misdiagnosis as physical abuse. Hong Kong Med J 2010; 16: 397- 399.